Transplantation of Umbilical Cord Blood Stem Cells for Treating Spinal Cord Injury

Stem Cell Reviews and Reports

Volumn 7, Issue 1, 2011, Pages 181-194

  Park, Dong Hyuk ^a   Lee, Jeong Hyun ^b   Borlongan, Cesario V ^c   Sanberg, Paul R ^c,d   Chung, Yong Gu ^a   Cho, Tai Hyoung ^a  

^a Korea University College of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

^c UNIVERSITY OF SOUTH FLORIDA   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

Animal models; Human umbilical cord blood; Spinal cord injury; Stem cells; Transplantation

Indexed keywords

ANIMALIA;

EID: 78751647262     PISSN: 15508943     EISSN: 15586804     Source Type: Journal    
DOI: 10.1007/s12015-010-9163-0     Document Type: Review

References (116)

1. The National Spinal Cord Injury Statistical Center. (2010). Spinal cord injury facts and figures at a glance. https://www. nscisc. uab. edu/public_content/pdf/Facts%20and%20Figures%20at%20a%20Glance%202010. pdf. Accessed 16 April 2010.
2. Bracken, M. B., Shepard, M. J., Hellenbrand, K. G., Collins, W. F., Leo, L. S., Freeman, D. F., et al. (1985). Methylprednisolone and neurological function 1 year after spinal cord injury. Results of the National Acute Spinal Cord Injury Study. Journal of Neurosurgery, 63(5), 704-713.
3. Bracken, M. B., Shepard, M. J., Collins, W. F., Holford, T. R., Young, W., Baskin, D. S., et al. (1990). A randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury. Results of the Second National Acute Spinal Cord Injury Study. New England Journal of Medicine, 322(20), 1405-1411.
4. Bracken, M. B., Shepard, M. J., Holford, T. R., Leo-Summers, L., Aldrich, E. F., Fazl, M., et al. (1997). Administration of methylprednisolone for 24 or 48 hours or tirilazad mesylate for 48 hours in the treatment of acute spinal cord injury. Results of the Third National Acute Spinal Cord Injury Randomized Controlled Trial. National Acute Spinal Cord Injury Study. Journal of the American Medical Association, 277(20), 1597-1604.
5. Short, D. J., El Masry, W. S., & Jones, P. W. (2000). High dose methylprednisolone in the management of acute spinal cord injury-a systematic review from a clinical perspective. Spinal Cord, 38(5), 273-286.
6. Coutts, M., & Keirstead, H. S. (2008). Stem cells for the treatment of spinal cord injury. Experimental Neurology, 209(2), 368-377.
7. Kim, B. G., Hwang, D. H., Lee, S. I., Kim, E. J., & Kim, S. U. (2007). Stem cell-based cell therapy for spinal cord injury. Cell Transplantation, 16(4), 355-364.
8. Chang, Y. C., Shyu, W. C., Lin, S. Z., & Li, H. (2007). Regenerative therapy for stroke. Cell Transplantation, 16(2), 171-181.
9. Johnson, P. J., Tatara, A., Shiu, A., & Sakiyama-Elbert, S. E. (2010). Controlled release of neurotrophin-3 and platelet-derived growth factor from fibrin scaffolds containing neural progenitor cells enhances survival and differentiation into neurons in a subacute model of SCI. Cell Transplantation, 19(1), 89-101.
10. Mothe, A. J., Kulbatski, I., Parr, A., Mohareb, M., & Tator, C. H. (2008). Adult spinal cord stem/progenitor cells transplanted as neurospheres preferentially differentiate into oligodendrocytes in the adult rat spinal cord. Cell Transplant, 17(7), 735-751.
11. Daar, A. S., Bhatt, A., Court, E., & Singer, P. A. (2004). Stem cell research and transplantation: science leading ethics. Transplantation Proceedings, 36(8), 2504-2506.
12. Henon, P. R. (2003). Human embryonic or adult stem cells: an overview on ethics and perspectives for tissue engineering. Advances in Experimental Medicine and Biology, 534, 27-45.
13. Riaz, S. S., Jauniaux, E., Stern, G. M., & Bradford, H. F. (2002). The controlled conversion of human neural progenitor cells derived from foetal ventral mesencephalon into dopaminergic neurons in vitro. Brain Research. Developmental Brain Research, 136(1), 27-34.
14. Sathananthan, A. H., & Trounson, A. (2005). Human embryonic stem cells and their spontaneous differentiation. Italian Journal of Anatomy and Embryology, 110(2 Suppl 1), 151-157.
15. Ramsay, N. K., Davies, S., Wagner, J., McGough, E., & McGlave, P. B. (1996). Bone marrow transplantation. New strategies for treating malignant disease. Minnesota Medicine, 79(4), 23-28.
16. Ferrari, G., Cusella-De Angelis, G., Coletta, M., Paolucci, E., Stornaiuolo, A., Cossu, G., et al. (1998). Muscle regeneration by bone marrow-derived myogenic progenitors. Science, 279(5356), 1528-1530.
17. Petersen, B. E., Bowen, W. C., Patrene, K. D., Mars, W. M., Sullivan, A. K., Murase, N., et al. (1999). Bone marrow as a potential source of hepatic oval cells. Science, 284(5417), 1168-1170.
18. Sanchez-Ramos, J., Song, S., Cardozo-Pelaez, F., Hazzi, C., Stedeford, T., Willing, A., et al. (2000). Adult bone marrow stromal cells differentiate into neural cells in vitro. Experimental Neurology, 164(2), 247-256.
19. Cho, S. R., Kim, Y. R., Kang, H. S., Yim, S. H., Park, C. I., Min, Y. H., et al. (2009). Functional recovery after the transplantation of neurally differentiated mesenchymal stem cells derived from bone barrow in a rat model of spinal cord injury. Cell Transplantation, 18(12), 1359-1368.
20. Armitage, J. O. (1994). Bone marrow transplantation. New England Journal of Medicine, 330(12), 827-838.
21. Newcomb, J. D., Sanberg, P. R., Klasko, S. K., & Willing, A. E. (2007). Umbilical cord blood research: current and future perspectives. Cell Transplantation, 16(2), 151-158.
22. Tse, W. & Laughlin, M. J. (2005). Umbilical cord blood transplantation: a new alternative option. Hematology/the Education Program of the American Society of Hematology. American Society of Hematology. Education Program, 377-383.
23. Knutsen, A. P., & Wall, D. A. (1999). Kinetics of T-cell development of umbilical cord blood transplantation in severe T-cell immunodeficiency disorders. Journal of Allergy and Clinical Immunology, 103(5 Pt 1), 823-832.
24. Vaziri, H., Dragowska, W., Allsopp, R. C., Thomas, T. E., Harley, C. B., & Lansdorp, P. M. (1994). Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proceedings of the National Academy of Sciences of the United States of America, 91(21), 9857-9860.
25. Willing, A. E., Lixian, J., Milliken, M., Poulos, S., Zigova, T., Song, S., et al. (2003). Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. Journal of Neuroscience Research, 73(3), 296-307.
26. Erices, A., Conget, P., & Minguell, J. J. (2000). Mesenchymal progenitor cells in human umbilical cord blood. British Journal of Haematology, 109(1), 235-242.
27. Berger, M. J., Adams, S. D., Tigges, B. M., Sprague, S. L., Wang, X. J., Collins, D. P., et al. (2006). Differentiation of umbilical cord blood-derived multilineage progenitor cells into respiratory epithelial cells. Cytotherapy, 8(5), 480-487.
28. Kim, J. W., Kim, S. Y., Park, S. Y., Kim, Y. M., Kim, J. M., Lee, M. H., et al. (2004). Mesenchymal progenitor cells in the human umbilical cord. Annals of Hematology, 83(12), 733-738.
29. Todaro, A. M., Pafumi, C., Pernicone, G., Munda, S., Pilastro, M. R., Russo, A., et al. (2000). Haematopoietic progenitors from umbilical cord blood. Blood Purification, 18(2), 144-147.
30. Nayar, B., Raju, G. M., & Deka, D. (2002). Hematopoietic stem/progenitor cell harvesting from umbilical cord blood. International Journal of Gynaecology and Obstetrics, 79(1), 31-32.
31. Broxmeyer, H. E., Hangoc, G., Cooper, S., Ribeiro, R. C., Graves, V., Yoder, M., et al. (1992). Growth characteristics and expansion of human umbilical cord blood and estimation of its potential for transplantation in adults. Proceedings of the National Academy of Sciences of the United States of America, 89(9), 4109-4113.
32. Nakahata, T., & Ogawa, M. (1982). Hemopoietic colony-forming cells in umbilical cord blood with extensive capability to generate mono- and multipotential hemopoietic progenitors. Journal of Clinical Investigation, 70(6), 1324-1328.
33. Frassoni, F., Podesta, M., Maccario, R., Giorgiani, G., Rossi, G., Zecca, M., et al. (2003). Cord blood transplantation provides better reconstitution of hematopoietic reservoir compared with bone marrow transplantation. Blood, 102(3), 1138-1141.
34. Pranke, P., Failace, R. R., Allebrandt, W. F., Steibel, G., Schmidt, F., & Nardi, N. B. (2001). Hematologic and immunophenotypic characterization of human umbilical cord blood. Acta Haematologica, 105(2), 71-76.
35. Chen, N., Hudson, J. E., Walczak, P., Misiuta, I., Garbuzova-Davis, S., Jiang, L., et al. (2005). Human umbilical cord blood progenitors: the potential of these hematopoietic cells to become neural. Stem Cells, 23(10), 1560-1570.
36. Mikami, T., Eguchi, M., Kurosawa, H., Sato, Y., Sugita, K., Suzumura, H., et al. (2002). Ultrastructural and cytochemical characterization of human cord blood cells. Medical Electron Microscopy, 35(2), 96-101.
37. Harris, D. T., Schumacher, M. J., Locascio, J., Besencon, F. J., Olson, G. B., DeLuca, D., et al. (1992). Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proceedings of the National Academy of Sciences of the United States of America, 89(21), 10006-10010.
38. D'Arena, G., Musto, P., Cascavilla, N., Di Giorgio, G., Fusilli, S., Zendoli, F., et al. (1998). Flow cytometric characterization of human umbilical cord blood lymphocytes: immunophenotypic features. Haematologica, 83(3), 197-203.
39. Zola, H., Fusco, M., Macardle, P. J., Flego, L., & Roberton, D. (1995). Expression of cytokine receptors by human cord blood lymphocytes: comparison with adult blood lymphocytes. Pediatric Research, 38(3), 397-403.
40. Gluckman, E., & Rocha, V. (2005). History of the clinical use of umbilical cord blood hematopoietic cells. Cytotherapy, 7(3), 219-227.
41. Rainsford, E., & Reen, D. J. (2002). Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. British Journal of Haematology, 116(3), 702-709.
42. Asseman, C., & Powrie, F. (1998). Interleukin 10 is a growth factor for a population of regulatory T cells. Gut, 42(2), 157-158.
43. Jiang, Q., Azuma, E., Hirayama, M., Iwamoto, S., Kumamoto, T., Kobayashi, M., et al. (2001). Functional immaturity of cord blood monocytes as detected by impaired response to hepatocyte growth factor. Pediatrics International, 43(4), 334-339.
44. Theilgaard-Monch, K., Raaschou-Jensen, K., Palm, H., Schjodt, K., Heilmann, C., Vindelov, L., et al. (2001). Flow cytometric assessment of lymphocyte subsets, lymphoid progenitors, and hematopoietic stem cells in allogeneic stem cell grafts. Bone Marrow Transplantation, 28(11), 1073-1082.
45. Willing, A. E., Eve, D. J., & Sanberg, P. R. (2007). Umbilical cord blood transfusions for prevention of progressive brain injury and induction of neural recovery: an immunological perspective. Regenerative Medicine, 2(4), 457-464.
46. Arpinati, M., Green, C. L., Heimfeld, S., Heuser, J. E., & Anasetti, C. (2000). Granulocyte-colony stimulating factor mobilizes T helper 2-inducing dendritic cells. Blood, 95(8), 2484-2490.
47. Garderet, L., Dulphy, N., Douay, C., Chalumeau, N., Schaeffer, V., Zilber, M. T., et al. (1998). The umbilical cord blood alphabeta T-cell repertoire: characteristics of a polyclonal and naive but completely formed repertoire. Blood, 91(1), 340-346.
48. Thomson, B. G., Robertson, K. A., Gowan, D., Heilman, D., Broxmeyer, H. E., Emanuel, D., et al. (2000). Analysis of engraftment, graft-versus-host disease, and immune recovery following unrelated donor cord blood transplantation. Blood, 96(8), 2703-2711.
49. Cardoso, A. A., Li, M. L., Batard, P., Hatzfeld, A., Brown, E. L., Levesque, J. P., et al. (1993). Release from quiescence of CD34+ CD38- human umbilical cord blood cells reveals their potentiality to engraft adults. Proceedings of the National Academy of Sciences of the United States of America, 90(18), 8707-8711.
50. Conrad, P. D., & Emerson, S. G. (1998). Ex vivo expansion of hematopoietic cells from umbilical cord blood for clinical transplantation. Journal of Leukocyte Biology, 64(2), 147-155.
51. Yin, A. H., Miraglia, S., Zanjani, E. D., Almeida-Porada, G., Ogawa, M., Leary, A. G., et al. (1997). AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood, 90(12), 5002-5012.
52. Kobari, L., Giarratana, M. C., Pflumio, F., Izac, B., Coulombel, L., & Douay, L. (2001). CD133+ cell selection is an alternative to CD34+ cell selection for ex vivo expansion of hematopoietic stem cells. Journal of Hematotherapy and Stem Cell Research, 10(2), 273-281.
53. Hao, S. G., Sun, G. L., Wu, W. L., & Wu, Y. L. (2003). Studies on the dynamics of biological characteristics of CD133+ cells from human umbilical cord blood during short-term culture. Zhongguo Shi Yan Xue Ye Xue Za Zhi, 11(6), 569-575.
54. Ma, Y., Zou, P., Xiao, J., & Huang, S. (2002). The expression and functional characteristics of AC133 antigen in cord blood hematopoietic cells. Zhonghua Nei Ke Za Zhi, 41(12), 798-800.
55. Garbuzova-Davis, S., Willing, A. E., Saporta, S., Bickford, P. C., Gemma, C., Chen, N., et al. (2006). Novel cell therapy approaches for brain repair. Progress in Brain Research, 157, 207-222.
56. Tamaki, S., Eckert, K., He, D., Sutton, R., Doshe, M., Jain, G., et al. (2002). Engraftment of sorted/expanded human central nervous system stem cells from fetal brain. Journal of Neuroscience Research, 69(6), 976-986.
57. Uchida, N., Buck, D. W., He, D., Reitsma, M. J., Masek, M., Phan, T. V., et al. (2000). Direct isolation of human central nervous system stem cells. Proceedings of the National Academy of Sciences of the United States of America, 97(26), 14720-14725.
58. Cheshier, S. H., Kalani, M. Y., Lim, M., Ailles, L., Huhn, S. L., & Weissman, I. L. (2009). A neurosurgeon's guide to stem cells, cancer stem cells, and brain tumor stem cells. Neurosurgery, 65(2), 237-249. discussion 249-250; quiz N236.
59. Sanchez-Ramos, J. R., Song, S., Kamath, S. G., Zigova, T., Willing, A., Cardozo-Pelaez, F., et al. (2001). Expression of neural markers in human umbilical cord blood. Experimental Neurology, 171(1), 109-115.
60. Bicknese, A. R., Goodwin, H. S., Quinn, C. O., Henderson, V. C., Chien, S. N., & Wall, D. A. (2002). Human umbilical cord blood cells can be induced to express markers for neurons and glia. Cell Transplantation, 11(3), 261-264.
61. Buzanska, L., Machaj, E. K., Zablocka, B., Pojda, Z., & Domanska-Janik, K. (2002). Human cord blood-derived cells attain neuronal and glial features in vitro. Journal of Cell Science, 115(Pt 10), 2131-2138.
62. Jurga, M., Markiewicz, I., Sarnowska, A., Habich, A., Kozlowska, H., Lukomska, B., et al. (2006). Neurogenic potential of human umbilical cord blood: neural-like stem cells depend on previous long-term culture conditions. Journal of Neuroscience Research, 83(4), 627-637.
63. Zigova, T., Song, S., Willing, A. E., Hudson, J. E., Newman, M. B., Saporta, S., et al. (2002). Human umbilical cord blood cells express neural antigens after transplantation into the developing rat brain. Cell Transplantation, 11(3), 265-274.
64. Goodwin, H. S., Bicknese, A. R., Chien, S. N., Bogucki, B. D., Quinn, C. O., & Wall, D. A. (2001). Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers. Biology of Blood and Marrow Transplantation, 7(11), 581-588.
65. McGuckin, C. P., Forraz, N., Allouard, Q., & Pettengell, R. (2004). Umbilical cord blood stem cells can expand hematopoietic and neuroglial progenitors in vitro. Experimental Cell Research, 295(2), 350-359.
66. Garbuzova-Davis, S., Willing, A. E., Zigova, T., Saporta, S., Justen, E. B., Lane, J. C., et al. (2003). Intravenous administration of human umbilical cord blood cells in a mouse model of amyotrophic lateral sclerosis: distribution, migration, and differentiation. Journal of Hematotherapy and Stem Cell Research, 12(3), 255-270.
67. Chen, N., Kamath, S., Newcomb, J., Hudson, J., Garbuzova-Davis, S., Bickford, P., et al. (2007). Trophic factor induction of human umbilical cord blood cells in vitro and in vivo. Journal of Neural Engineering, 4(2), 130-145.
68. Darian-Smith, C. (2009). Synaptic plasticity, neurogenesis, and functional recovery after spinal cord injury. Neuroscientist, 15(2), 149-165.
69. Schwab, M. E., & Bartholdi, D. (1996). Degeneration and regeneration of axons in the lesioned spinal cord. Physiological Reviews, 76(2), 319-370.
70. Waxman, S. G., Ransom, B. R., & Stys, P. K. (1991). Non-synaptic mechanisms of Ca(2+)-mediated injury in CNS white matter. Trends in Neuroscience, 14(10), 461-468.
71. Li, Y., & Raisman, G. (1994). Schwann cells induce sprouting in motor and sensory axons in the adult rat spinal cord. Journal of Neuroscience, 14(7), 4050-4063.
72. Fawcett, J. W., & Asher, R. A. (1999). The glial scar and central nervous system repair. Brain Research Bulletin, 49(6), 377-391.
73. Finkelstein, S. D., Gillespie, J. A., Markowitz, R. S., Johnson, D. D., & Black, P. (1990). Experimental spinal cord injury: qualitative and quantitative histopathologic evaluation. Journal of Neurotrauma, 7(1), 29-40.
74. Guest, J. D., Hiester, E. D., & Bunge, R. P. (2005). Demyelination and Schwann cell responses adjacent to injury epicenter cavities following chronic human spinal cord injury. Experimental Neurology, 192(2), 384-393.
75. Crowe, M. J., Bresnahan, J. C., Shuman, S. L., Masters, J. N., & Beattie, M. S. (1997). Apoptosis and delayed degeneration after spinal cord injury in rats and monkeys. Nature Medicine, 3(1), 73-76.
76. Dong, H., Fazzaro, A., Xiang, C., Korsmeyer, S. J., Jacquin, M. F., & McDonald, J. W. (2003). Enhanced oligodendrocyte survival after spinal cord injury in Bax-deficient mice and mice with delayed Wallerian degeneration. J Neurosci, 23(25), 8682-8691.
77. David, S., & Aguayo, A. J. (1981). Axonal elongation into peripheral nervous system "bridges" after central nervous system injury in adult rats. Science, 214(4523), 931-933.
78. Caroni, P., & Schwab, M. E. (1988). Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron, 1(1), 85-96.
79. Chen, M. S., Huber, A. B., van der Haar, M. E., Frank, M., Schnell, L., Spillmann, A. A., et al. (2000). Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature, 403(6768), 434-439.
80. McKerracher, L., David, S., Jackson, D. L., Kottis, V., Dunn, R. J., & Braun, P. E. (1994). Identification of myelin-associated glycoprotein as a major myelin-derived inhibitor of neurite growth. Neuron, 13(4), 805-811.
81. Prinjha, R., Moore, S. E., Vinson, M., Blake, S., Morrow, R., Christie, G., et al. (2000). Inhibitor of neurite outgrowth in humans. Nature, 403(6768), 383-384.
82. Wang, K. C., Koprivica, V., Kim, J. A., Sivasankaran, R., Guo, Y., Neve, R. L., et al. (2002). Oligodendrocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature, 417(6892), 941-944.
83. Hannila, S. S., Siddiq, M. M., & Filbin, M. T. (2007). Therapeutic approaches to promoting axonal regeneration in the adult mammalian spinal cord. International Review of Neurobiology, 77, 57-105.
84. Davies, S. J., Fitch, M. T., Memberg, S. P., Hall, A. K., Raisman, G., & Silver, J. (1997). Regeneration of adult axons in white matter tracts of the central nervous system. Nature, 390(6661), 680-683.
85. McDonald, J. W., & Belegu, V. (2006). Demyelination and remyelination after spinal cord injury. Journal of Neurotrauma, 23(3-4), 345-359.
86. Zhao, Z. M., Li, H. J., Liu, H. Y., Lu, S. H., Yang, R. C., Zhang, Q. J., et al. (2004). Intraspinal transplantation of CD34+ human umbilical cord blood cells after spinal cord hemisection injury improves functional recovery in adult rats. Cell Transplantation, 13(2), 113-122.
87. Dasari, V. R., Spomar, D. G., Gondi, C. S., Sloffer, C. A., Saving, K. L., Gujrati, M., et al. (2007). Axonal remyelination by cord blood stem cells after spinal cord injury. Journal of Neurotrauma, 24(2), 391-410.
88. Cho, S. R., Yang, M. S., Yim, S. H., Park, J. H., Lee, J. E., Eom, Y. W., et al. (2008). Neurally induced umbilical cord blood cells modestly repair injured spinal cords. Neuroreport, 19(13), 1259-1263.
89. Saporta, S., Kim, J. J., Willing, A. E., Fu, E. S., Davis, C. D., & Sanberg, P. R. (2003). Human umbilical cord blood stem cells infusion in spinal cord injury: engraftment and beneficial influence on behavior. Journal of Hematotherapy and Stem Cell Research, 12(3), 271-278.
90. Kao, C. H., Chen, S. H., Chio, C. C., & Lin, M. T. (2008). Human umbilical cord blood-derived CD34+ cells may attenuate spinal cord injury by stimulating vascular endothelial and neurotrophic factors. Shock, 29(1), 49-55.
91. Kuh, S. U., Cho, Y. E., Yoon, D. H., Kim, K. N., & Ha, Y. (2005). Functional recovery after human umbilical cord blood cells transplantation with brain-derived neutrophic factor into the spinal cord injured rat. Acta Neurochirurgica (Wien), 147(9), 985-992. discussion 992.
92. Lim, J. H., Byeon, Y. E., Ryu, H. H., Jeong, Y. H., Lee, Y. W., Kim, W. H., et al. (2007). Transplantation of canine umbilical cord blood-derived mesenchymal stem cells in experimentally induced spinal cord injured dogs. Journal of Veterinary Science, 8(3), 275-282.
93. Young, W. (2009). Review of lithium effects on brain and blood. Cell Transplantation, 18(9), 951-975.
94. Kang, K. S., Kim, S. W., Oh, Y. H., Yu, J. W., Kim, K. Y., Park, H. K., et al. (2005). A 37-year-old spinal cord-injured female patient, transplanted of multipotent stem cells from human UC blood, with improved sensory perception and mobility, both functionally and morphologically: a case study. Cytotherapy, 7(4), 368-373.
95. Ha, Y., Choi, J. U., Yoon, D. H., Yeon, D. S., Lee, J. J., Kim, H. O., et al. (2001). Neural phenotype expression of cultured human cord blood cells in vitro. Neuroreport, 12(16), 3523-3527.
96. Xiao, J., Nan, Z., Motooka, Y., & Low, W. C. (2005). Transplantation of a novel cell line population of umbilical cord blood stem cells ameliorates neurological deficits associated with ischemic brain injury. Stem Cells and Development, 14(6), 722-733.
97. Borlongan, C. V., Hadman, M., Sanberg, C. D., & Sanberg, P. R. (2004). Central nervous system entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke, 35(10), 2385-2389.
98. Arien-Zakay, H., Lecht, S., Bercu, M. M., Tabakman, R., Kohen, R., Galski, H., et al. (2009). Neuroprotection by cord blood neural progenitors involves antioxidants, neurotrophic and angiogenic factors. Experimental Neurology, 216(1), 83-94.
99. Li, H. J., Liu, H. Y., Zhao, Z. M., Lu, S. H., Yang, R. C., Zhu, H. F., et al. (2004). Transplantation of human umbilical cord stem cells improves neurological function recovery after spinal cord injury in rats. Zhongguo Yi Xue Ke Xue Yuan Xue Bao, 26(1), 38-42.
100. Nishio, Y., Koda, M., Kamada, T., Someya, Y., Yoshinaga, K., Okada, S., et al. (2006). The use of hemopoietic stem cells derived from human umbilical cord blood to promote restoration of spinal cord tissue and recovery of hindlimb function in adult rats. Journal of Neurosurgery Spine, 5(5), 424-433.
101. Dasari, V. R., Spomar, D. G., Li, L., Gujrati, M., Rao, J. S., & Dinh, D. H. (2008). Umbilical cord blood stem cell mediated downregulation of fas improves functional recovery of rats after spinal cord injury. Neurochemistry Research, 33(1), 134-149.
102. Dasari, V. R., Veeravalli, K. K., Tsung, A. J., Gondi, C. S., Gujrati, M., Dinh, D., et al. (2009). Neuronal apoptosis inhibited by cord blood stem cells after spinal cord injury. Journal of Neurotrauma, 26(11), 2057-2069.
103. Hall, A. A., Guyer, A. G., Leonardo, C. C., Ajmo, C. T., Jr., Collier, L. A., Willing, A. E., et al. (2009). Human umbilical cord blood cells directly suppress ischemic oligodendrocyte cell death. Journal of Neuroscience Research, 87(2), 333-341.
104. Veeravalli, K. K., Dasari, V. R., Tsung, A. J., Dinh, D. H., Gujrati, M., Fassett, D., et al. (2009). Stem cells downregulate the elevated levels of tissue plasminogen activator in rats after spinal cord injury. Neurochemistry Research, 34(7), 1183-1194.
105. Krupinski, J., Kaluza, J., Kumar, P., Kumar, S., & Wang, J. M. (1994). Role of angiogenesis in patients with cerebral ischemic stroke. Stroke, 25(9), 1794-1798.
106. Teng, H., Zhang, Z. G., Wang, L., Zhang, R. L., Zhang, L., Morris, D., et al. (2008). Coupling of angiogenesis and neurogenesis in cultured endothelial cells and neural progenitor cells after stroke. Journal of Cerebral Blood Flow and Metabolism, 28(4), 764-771.
107. Rizvanov, A. A., Kiyasov, A. P., Gaziziov, I. M., Yilmaz, T. S., Kaligin, M. S., Andreeva, D. I., et al. (2008). Human umbilical cord blood cells transfected with VEGF and L(1)CAM do not differentiate into neurons but transform into vascular endothelial cells and secrete neuro-trophic factors to support neuro-genesis-a novel approach in stem cell therapy. Neurochemistry International, 53(6-8), 389-394.
108. Vendrame, M., Gemma, C., de Mesquita, D., Collier, L., Bickford, P. C., Sanberg, C. D., et al. (2005). Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells and Development, 14(5), 595-604.
109. Vendrame, M., Gemma, C., Pennypacker, K. R., Bickford, P. C., Davis Sanberg, C., Sanberg, P. R., et al. (2006). Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Experimental Neurology, 199(1), 191-200.
110. Hu, C. H., Wu, G. F., Wang, X. Q., Yang, Y. H., Du, Z. M., He, X. H., et al. (2006). Transplanted human umbilical cord blood mononuclear cells improve left ventricular function through angiogenesis in myocardial infarction. Chinese Medical Journal (Engl), 119(18), 1499-1506.
111. Kim, B. O., Tian, H., Prasongsukarn, K., Wu, J., Angoulvant, D., Wnendt, S., et al. (2005). Cell transplantation improves ventricular function after a myocardial infarction: a preclinical study of human unrestricted somatic stem cells in a porcine model. Circulation, 112(9 Suppl), I96-104.
112. Pesce, M., Orlandi, A., Iachininoto, M. G., Straino, S., Torella, A. R., Rizzuti, V., et al. (2003). Myoendothelial differentiation of human umbilical cord blood-derived stem cells in ischemic limb tissues. Circulation Research, 93(5), e51-62.
113. Jang, J. H., Kim, S. K., Choi, J. E., Kim, Y. J., Lee, H. W., Kang, S. Y., et al. (2007). Endothelial progenitor cell differentiation using cryopreserved, umbilical cord blood-derived mononuclear cells. Acta Pharmacologica Sinica, 28(3), 367-374.
114. Ding, D. C., Shyu, W. C., Chiang, M. F., Lin, S. Z., Chang, Y. C., Wang, H. J., et al. (2007). Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiology of Disease, 27(3), 339-353.
115. Taguchi, A., Soma, T., Tanaka, H., Kanda, T., Nishimura, H., Yoshikawa, H., et al. (2004). Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. Journal of Clinical Investigation, 114(3), 330-338.
116. Chen, C. T., Foo, N. H., Liu, W. S., & Chen, S. H. (2008). Infusion of human umbilical cord blood cells ameliorates hind limb dysfunction in experimental spinal cord injury through anti-inflammatory, vasculogenic and neurotrophic mechanisms. Pediatrics and Neonatology, 49(3), 77-83.